A popular fermented soybean food of Northeast India exerted promising antihyperglycemic potential via stimulating PI3K/AKT/AMPK/GLUT4 signaling pathways and regulating muscle glucose metabolism in type 2 diabetes
Authors:
- 7 September 2022
- journal article
- research article
- Published by Wiley in Journal of Food Biochemistry
- Vol. 46 (12) , e14385
Abstract
This study examined the antidiabetic efficacy of popular fermented soybean foods (FSF) of Northeast (NE) India. Results showed that among different FSF, aqueous extract of Hawaijar (AEH), a traditional FSF of Manipur, NE India, significantly augmented glucose utilization in cultured myotubes treated with high glucose (HG, 25 mM). Furthermore, AEH also upregulated glucose uptake, glucose-6-phosphate level, and phopho-PI3K/phospho-AKT/phospho-AMPK/GLUT4 protein expression in HG-treated myotubes. In vivo studies demonstrated that AEH supplementation (50, 100, or 200 mg/kg body weight/day, oral gavaging, 16 weeks) reduced body weight, fasting blood glucose, glycated hemoglobin, insulin resistance, and glucose intolerance in rats fed with high-fat diet (HFD). AEH supplementation stimulated phopho-PI3K/phospho-AKT/phospho-AMPK/GLUT4 signaling cascades involved in glucose metabolism of muscle tissues in diabetic rats. Chemical profiling of AEH (SDS-PAGE, immunoblotting, and HRMS) suggests the possible role of bioactive proteins/peptides and isoflavones underlying the antihyperglycemic potential AEH. Results from this study will be helpful for developing food-based prophylactics/therapeutics in managing hyperglycemia. PRACTICAL APPLICATIONS: Fermented soybean foods are gaining acceptance due to multiple health benefits. This study for the first time reports the antidiabetic potential of Hawaijar, an indigenous fermented soybean food of North-East India. Higher abundance of bioactive compounds (isoflavones and proteins/peptides) in Hawaijar may be responsible for the alleviation of impaired glucose metabolism associated with diabetes. The findings may be helpful for the development of a novel therapeutic to achieve better control of hyperglycemia and improve the lives of the patient population with diabetes.Keywords
This publication has 35 references indexed in Scilit:
- L-cysteine and hydrogen sulfide increase PIP3 and AMPK/PPARγ expression and decrease ROS and vascular inflammation markers in high glucose treated human U937 monocytesJournal of Cellular Biochemistry, 2013
- Vitamin D Up-regulates Glucose Transporter 4 (GLUT4) Translocation and Glucose Utilization Mediated by Cystathionine-γ-lyase (CSE) Activation and H2S Formation in 3T3L1 AdipocytesJournal of Biological Chemistry, 2012
- Anti-diabetic functions of soy isoflavone genistein: mechanisms underlying its effects on pancreatic β-cell functionFood & Function, 2012
- A Review about the Effect of Life style Modification on Diabetes and Quality of LifeGlobal Journal of Health Science, 2012
- Antidiabetic effects of fermented soybean products on type 2 diabetesNutrition Research, 2010
- Protein hydrolysates from β‐conglycinin enriched soybean genotypes inhibit lipid accumulation and inflammation in vitroMolecular Nutrition & Food Research, 2009
- Blockade of sensory abnormalities and kinin B1 receptor expression by N-Acetyl-l-Cysteine and ramipril in a rat model of insulin resistanceEuropean Journal of Pharmacology, 2008
- Immunoreactivity reduction of soybean meal by fermentation, effect on amino acid composition and antigenicity of commercial soy productsFood Chemistry, 2008
- Emulsifying properties of soy protein isolate fractions obtained by isoelectric precipitationJournal of the Science of Food and Agriculture, 2001
- Reduction of the Soybean Allergenicity by the Fermentation with Bacillus natto.Food Science and Technology International, Tokyo, 1995